205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.98%
Revenue growth 1.25-1.5x ON's 5.69%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
11.21%
Gross profit growth above 1.5x ON's 6.58%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
25.22%
EBIT growth above 1.5x ON's 2.38%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
25.22%
Operating income growth above 1.5x ON's 2.38%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
27.21%
Net income growth above 1.5x ON's 0.79%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
30.95%
EPS growth of 30.95% while ON is zero. Bruce Berkowitz would see if minimal gains can accelerate over time.
28.57%
Positive diluted EPS growth while ON is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-1.39%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-1.43%
Reduced diluted shares while ON is at 3.69%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
0.53%
Dividend growth of 0.53% while ON is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
70.49%
Similar OCF growth to ON's 77.62%. Walter Schloss would assume comparable operations or industry factors.
90.47%
FCF growth 50-75% of ON's 132.37%. Martin Whitman would see if structural disadvantages exist in generating free cash.
59.81%
Positive 10Y revenue/share CAGR while ON is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
96.53%
Positive 5Y CAGR while ON is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
37.60%
3Y revenue/share CAGR above 1.5x ON's 10.56%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
205.28%
Positive long-term OCF/share growth while ON is negative. John Neff would see a structural advantage in sustained cash generation.
226.83%
Below 50% of ON's 1517.32%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
98.43%
3Y OCF/share CAGR at 50-75% of ON's 181.88%. Martin Whitman would suspect weaker recent execution or product competitiveness.
-50.56%
Negative 10Y net income/share CAGR while ON is at 26.07%. Joel Greenblatt sees a major red flag in long-term profit erosion.
397.85%
5Y net income/share CAGR 1.25-1.5x ON's 288.27%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
68.28%
Below 50% of ON's 303.93%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
92.20%
Positive growth while ON is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
21.10%
Below 50% of ON's 93.68%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
5.44%
Below 50% of ON's 89.66%. Michael Burry suspects a serious short-term disadvantage in building book value.
288.56%
Dividend/share CAGR of 288.56% while ON is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
278.60%
Dividend/share CAGR of 278.60% while ON is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
286.61%
3Y dividend/share CAGR of 286.61% while ON is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
6.64%
AR growth well above ON's 12.38%. Michael Burry fears inflated revenue or higher default risk in the near future.
1.83%
We show growth while ON is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-2.11%
Negative asset growth while ON invests at 6.91%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-1.74%
We have a declining book value while ON shows 70.43%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-1.63%
Our R&D shrinks while ON invests at 6.17%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
1.18%
SG&A declining or stable vs. ON's 9.26%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.